Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults. (Q48595553)

13 February 2018

title

Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults. (English)

1 reference

13 February 2018

0 references

0 references

1 reference

Germán Reyes-Botero

1

1 reference

13 February 2018

Florence Laigle-Donadey

2

1 reference

13 February 2018

Karima Mokhtari

3

1 reference

13 February 2018

Nadine Martin-Duverneuil

4

1 reference

13 February 2018

Jean-Yves Delattre

5

1 reference

13 February 2018

publication date

20 August 2014

1 reference

13 February 2018

Journal of Neuro-Oncology

published in

1 reference

13 February 2018

volume

120

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

581-586

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-014-1589-9

exact match

0 references

cites work

Brainstem glioma: comparative study of clinico-radiological presentation, pathology and outcome in children and adults

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Brainstem gliomas in adults: prognostic factors and classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Natural history and management of brainstem gliomas in adults. A retrospective Italian study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Correlation between magnetic resonance imaging findings and histological diagnosis of intrinsic brainstem lesions in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Stereotactic biopsies of focal brainstem lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1589-9

Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25139026

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-014-1589-9

1 reference

13 February 2018

PubMed ID

25139026

1 reference

13 February 2018